{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T04:29:52Z","timestamp":1773721792963,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T00:00:00Z","timestamp":1489622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ijcard.2017.03.052","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T03:05:37Z","timestamp":1489460737000},"page":"79-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Systemic application of sirolimus prevents neointima formation not via a direct anti-proliferative effect but via its anti-inflammatory properties"],"prefix":"10.1016","volume":"238","author":[{"given":"Jan-Marcus","family":"Daniel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Dutzmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannes","family":"Brunsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann","family":"Bauersachs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00fcdiger","family":"Braun-Dullaeus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel G.","family":"Sedding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2017.03.052_bb0005","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/nm1102-1249","article-title":"Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies","volume":"8","author":"Dzau","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijcard.2017.03.052_bb0010","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1161\/01.CIR.0000163587.36485.A7","article-title":"Molecular basis of restenosis and drug-eluting stents","volume":"111","author":"Costa","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.03.052_bb0015","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0140-6736(12)61336-1","article-title":"Stent thrombosis and major clinical events at 3years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial","volume":"380","author":"Camenzind","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2017.03.052_bb0020","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2017.03.052_bb0025","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa0910496","article-title":"Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease","volume":"362","author":"Stone","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2017.03.052_bb0030","doi-asserted-by":"crossref","first-page":"C507","DOI":"10.1152\/ajpcell.00201.2003","article-title":"The mTOR\/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation","volume":"286","author":"Martin","year":"2004","journal-title":"American journal of physiology Cell physiology."},{"key":"10.1016\/j.ijcard.2017.03.052_bb0035","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1161\/01.CIR.103.10.1396","article-title":"Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy: detection of FK506-binding protein 12 upregulation","volume":"103","author":"Zohlnhofer","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.03.052_bb0040","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/01.CIR.0000155612.47040.17","article-title":"Potent inhibitory effect of sirolimus on circulating vascular progenitor cells","volume":"111","author":"Fukuda","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.03.052_bb0045","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nm0402-403","article-title":"Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis","volume":"8","author":"Sata","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijcard.2017.03.052_bb0050","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1161\/01.RES.0000096651.13001.B4","article-title":"Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries","volume":"93","author":"Tanaka","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2017.03.052_bb0055","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1161\/ATVBAHA.110.209692","article-title":"Time-course analysis on the differentiation of bone marrow-derived progenitor cells into smooth muscle cells during neointima formation","volume":"30","author":"Daniel","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcard.2017.03.052_bb0060","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1161\/CIRCULATIONAHA.110.965202","article-title":"Bone marrow-derived cells contribute to vascular inflammation but do not differentiate into smooth muscle cell lineages","volume":"122","author":"Iwata","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.03.052_bb0065","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.yjmcc.2010.10.030","article-title":"Circulating smooth muscle progenitor cells in arterial remodeling","volume":"50","author":"Daniel","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijcard.2017.03.052_bb0070","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/stem.1939","article-title":"Hematopoietic stem\/progenitor cells directly contribute to arteriosclerotic progression via integrin beta2","volume":"33","author":"Wang","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.ijcard.2017.03.052_bb0075","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.carrev.2014.10.008","article-title":"Dual role of circulating endothelial progenitor cells in stent struts endothelialisation and neointimal regrowth: a substudy of the IN-PACT CORO trial","volume":"16","author":"De Maria","year":"2015","journal-title":"Cardiovascular revascularization medicine: including molecular interventions."},{"key":"10.1016\/j.ijcard.2017.03.052_bb0080","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1161\/01.CIR.0000060487.15126.56","article-title":"Stent-induced expression and activation of the leukocyte integrin Mac-1 is associated with neointimal thickening and restenosis","volume":"107","author":"Inoue","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.03.052_bb0085","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00005072-199409000-00005","article-title":"Differential expression of ICAM-1, VCAM-1 and their ligands LFA-1, Mac-1, CD43, VLA-4, and MHC class II antigens in murine toxoplasma encephalitis: a light microscopic and ultrastructural immunohistochemical study","volume":"53","author":"Deckert-Schluter","year":"1994","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ijcard.2017.03.052_bb0090","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.drudis.2015.05.006","article-title":"Sirolimus and everolimus in kidney transplantation","volume":"20","author":"Moes","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijcard.2017.03.052_bb0095","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.healun.2014.11.025","article-title":"De novo sirolimus with low-dose tacrolimus versus full-dose tacrolimus with mycophenolate mofetil after heart transplantation--8-year results","volume":"34","author":"Guethoff","year":"2015","journal-title":"The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation."},{"key":"10.1016\/j.ijcard.2017.03.052_bb0100","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ccd.22301","article-title":"Systemic rapamycin without loading dose for restenosis prevention after coronary bare metal stent implantation","volume":"75","author":"Stojkovic","year":"2010","journal-title":"Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography & Interventions."},{"key":"10.1016\/j.ijcard.2017.03.052_bb0105","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ccd.20799","article-title":"Systemic immunosuppressive therapy inhibits in-stent restenosis in patients with renal allograft","volume":"68","author":"Jung","year":"2006","journal-title":"Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography & Interventions."},{"key":"10.1016\/j.ijcard.2017.03.052_bb0110","doi-asserted-by":"crossref","first-page":"5726","DOI":"10.4049\/jimmunol.151.10.5726","article-title":"Murine recipients of fully mismatched donor marrow are protected from lethal graft-versus-host disease by the in vivo administration of rapamycin but develop an autoimmune-like syndrome","volume":"151","author":"Blazar","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijcard.2017.03.052_bb0115","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00007890-199602270-00001","article-title":"The immunosuppressive effect of rapamycin on mouse small bowel transplantation","volume":"61","author":"Chen","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.ijcard.2017.03.052_bb0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1523-1755.2001.00460.x","article-title":"Rapamycin in transplantation: a review of the evidence","volume":"59","author":"Saunders","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.ijcard.2017.03.052_bb0125","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/cvr\/cvu162","article-title":"Inhibition of miR-92a improves re-endothelialization and prevents neointima formation following vascular injury","volume":"103","author":"Daniel","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2017.03.052_bb0130","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/ATVBAHA.115.305974","article-title":"Regulator of G-protein signaling 5 prevents smooth muscle cell proliferation and attenuates neointima formation","volume":"36","author":"Daniel","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"97","key":"10.1016\/j.ijcard.2017.03.052_bb0135","doi-asserted-by":"crossref","DOI":"10.3791\/52561","article-title":"A murine model of arterial restenosis: technical aspects of femoral wire injury","volume":"10","author":"Takayama","year":"2015","journal-title":"Journal of visualized experiments: JoVE"},{"key":"10.1016\/j.ijcard.2017.03.052_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081325","article-title":"Anti-remodeling effects of rapamycin in experimental heart failure: dose response and interaction with angiotensin receptor blockade","volume":"8","author":"Bishu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2017.03.052_bb0145","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/01.CIR.0000057979.36322.88","article-title":"Rapamycin attenuates load-induced cardiac hypertrophy in mice","volume":"107","author":"Shioi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.03.052_bb0150","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.111.243386","article-title":"Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use","volume":"110","author":"Fadini","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2017.03.052_bb0155","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/ATVBAHA.110.218578","article-title":"Bone marrow-derived smooth muscle-like cells are infrequent in advanced primary atherosclerotic plaques but promote atherosclerosis","volume":"31","author":"Yu","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcard.2017.03.052_bb0160","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/CIRCRESAHA.109.194357","article-title":"3-Deazaadenosine prevents smooth muscle cell proliferation and neointima formation by interfering with Ras signaling","volume":"104","author":"Sedding","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2017.03.052_bb0165","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1084\/jem.20131125","article-title":"Rapamycin antagonizes TNF induction of VCAM-1 on endothelial cells by inhibiting mTORC2","volume":"211","author":"Wang","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ijcard.2017.03.052_bb0170","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0019-4832(12)60086-8","article-title":"Systemic exposure of sirolimus after coronary stent implantation in patients with de novo coronary lesions: Supralimus-Core(R) pharmacokinetic study","volume":"64","author":"Thakkar","year":"2012","journal-title":"Indian Heart J."},{"key":"10.1016\/j.ijcard.2017.03.052_bb0175","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/TP.0b013e318187bab0","article-title":"Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial","volume":"86","author":"Gaber","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.ijcard.2017.03.052_bb0180","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jcin.2012.10.018","article-title":"The REMEDEE trial: a randomized comparison of a combination sirolimus-eluting endothelial progenitor cell capture stent with a paclitaxel-eluting stent","volume":"6","author":"Haude","year":"2013","journal-title":"JACC Cardiovascular interventions."},{"key":"10.1016\/j.ijcard.2017.03.052_bb0185","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.amjcard.2005.06.042","article-title":"Peripheral CD34+ cells and the risk of in-stent restenosis in patients with coronary heart disease","volume":"96","author":"Schober","year":"2005","journal-title":"Am. J. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752731731611X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752731731611X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T23:28:50Z","timestamp":1719098930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016752731731611X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":37,"alternative-id":["S016752731731611X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.03.052","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic application of sirolimus prevents neointima formation not via a direct anti-proliferative effect but via its anti-inflammatory properties","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.03.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}